Header Logo

Connection

STACEY BERG to Response Evaluation Criteria in Solid Tumors

Back to Details
This is a "connection" page, showing publications STACEY BERG has written about Response Evaluation Criteria in Solid Tumors.
STACEY BERG
Connection Strength
0.044
Response Evaluation Criteria in Solid Tumors
  1. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 04; 21(4):541-550.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.